According to a report by Grand View Research, Inc., the global circulating tumor cells (CTC) market is estimated to reach a valuation of USD 11.55 billion by 2022. Growing requirement for advanced diagnostic techniques to timely detect and monitor chronic diseases such as cancer is anticipated to propel the market during the forecast period (2017 to 2022).... Continue Reading →